Correlation Between BridgeBio Pharma and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and Coya Therapeutics, Common, you can compare the effects of market volatilities on BridgeBio Pharma and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and Coya Therapeutics,.
Diversification Opportunities for BridgeBio Pharma and Coya Therapeutics,
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BridgeBio and Coya is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between BridgeBio Pharma and Coya Therapeutics,
Given the investment horizon of 90 days BridgeBio Pharma is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, BridgeBio Pharma is 1.61 times less risky than Coya Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 580.00 in Coya Therapeutics, Common on September 8, 2024 and sell it today you would earn a total of 32.00 from holding Coya Therapeutics, Common or generate 5.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
BridgeBio Pharma vs. Coya Therapeutics, Common
Performance |
Timeline |
BridgeBio Pharma |
Coya Therapeutics, Common |
BridgeBio Pharma and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BridgeBio Pharma and Coya Therapeutics,
The main advantage of trading using opposite BridgeBio Pharma and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |